DOI: 10.6653/MoCICHE.201808_45(4).0007 emerging contaminants or chemicals of emerging concernnontarget species Kümmerer 2004 Cyclophosphamide 6 ~ 17 ng/l [1,2] 6 ~ 4,486 ng/l [1,3,4] 2.2 ~ 10.1 ng/l Zuccato et al. [5] ~ 0.06 ~ 0.17 ng/l [2] 5-fluorouracil 124 ng/l [6,7] 0.09 ~ 4.0 ng/l [8] 5-fluorouracil [9] Ifosfamide 6 ~ 2,900 ng/l [2,10,11,12] 10,647 ng/l [3,10] 5-fluorouracil [13] cyclophosphamide cyclophosphamide [13] ifosfamide cyclophosphamide [14] methotrexate [15] NHI cyclophosphamide 27 ~ 272 5-fluorouracil 74 ~ 297 methotrexate 6 ~ 12,489 BNHI 2005 cyclophosphamide 5-fluorouracil ifosfamide methotrexate 1 Cyclophosphamide ifosfamide 38 Vol. 45, No. 4 August 2018
1 Compounds Structure Compounds Structure Cyclophosphamide C 7 H 15 Cl 2 N 2 O 2 P MW: 261.1 5-Fluorouracil C 4 H 3 FN 2 O 2 MW: 130.1 Ifosfamide C 7 H 15 C l2 N 2 O 2 P MW: 261.1 Methotrexate C 20 H 22 N 8 O 2 MW: 454.4 [1,2,16] 5-fluorouracil 50 30 [17] [18-24] methotrexate cyclophosphamide 5-fluorouracil 12,500 272 297 2011 ~ 2012 [25] 13 20 1 11 cyclophosphamide 5-fluorouracil ifosfamide 5-fluorouracil 1,477 ng/l cyclophosphamide 1,169 ng/l5-fluorouracil 161.5 ng/l cyclophosphamide 96.0 ng/ L 5-fluorouracil cyclophosphamide ifosfamide 302.1 ng/l 398.7 ng/l 204.6 ng/l 5-fluorouracil 80 ng/l cyclophosphamide ifosfamide 41.9 ng/l 15.1 ng/l 5-fluorouracil 1 Vol. 45, No. 4 August 2018 39
2 SSDOMs HCO 3 NO 3 DOMs HCO 3 NO 3 photoreactants hydroxyl radical OH singlet oxygen 1 O 2 triplet-state DOM 3 DOM* aqueous electrons e aq alkyl peroxy radicals ROO carbonate radicals CO 3 photosensitizers photoreactants photoreactants/photosensitizers DOMs DOMs 3 DOM* 1 O 2 3 40 Vol. 45, No. 4 August 2018
OH OH CO 3 2 2 Photoreactants Source Reaction mechanism 3 DOM* DOMs DOM+hv 1 DOM* 3 DOM* 1 O 2 DOMs, O 2 DOM+hv 1 DOM* 3 DOM* 3 DOM*+ 3 O 2 1 O 2 OH NO 3 NO 3 +hv NO 3 * NO 2 + O O +H 2 O OH+OH CO 3 [26-28] NO 3, HCO 3 NO 3 +hv NO 3 * NO 2 + O O +H 2 O OH+OH OH+ HCO 3 CO 3 ph 5-fluorouracil cyclophosphamide 5-fluorouracil cyclophosphamide DI water 5-fluorouracil 56 ± 11 methotrexate 27.6 ± 3.7 cyclophosphamide ifosfamide [25] 5-fluorouracil cyclophosphamide ifosfamide methotrexate 9.2 57 ± 6 38 7.7 ± 0.2 cyclophosphamide ph 5-fluorouracil ifosfamide methotrexate 5-fluorouracil CO 3 [25] 5-fluorouracil cyclophosphamide half lethal concentration, LC 50 half maximal effect concentration, EC 50 half maximal inhibitory concentration, IC 50 noobserved-effect concentration, NOEC predicted or measured environmental concentration Predicted No Effect Concentration, PNEC RQ, risk quotient = MEC/PNEC 0.1 0.1 ~ 1 1 [29] PNEC assessment factor measured environmental concentration PNEC 5-fluorouracil 1 RQ 15 5-fluorouracil 5-fluorouracil 93% 42 [30] cyclophosphamide 5-fluorouracil Vol. 45, No. 4 August 2018 41
- MOST 102-2221-E-002-009-MY3 NHRI- EX104-10120PC Online 1. Steger-Hartmann, T., Kümmerer, K. and Hartmann, A. (1997), Biological degradation of cyclophosphamide and its occurrence in sewage water, Ecotoxicol. Environ. Safe, 36(2), 174-179. 2. Buerge, I.J., Buser, H.R., Poiger, T. and Muller, M.D. (2006), Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters, Environmental Science & Technology, 40, 7242-7250. 3. Yin, J., Shao, B., Zhang, J. and Li, K. (2010), A preliminary study on the occurrence of cytostatic drugs in hospital effluents in Beijing, China, Bulletin of Environmental Contamination and Toxicology, 84, 39-45. 4. Steger-Hartmann, T., Kümmerer, K. and Schecker, J. (1996), Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by twostep solid-phase extraction and gas chromatography mass spectrometry, J. Chromatogr., A. 726 (1-2), 179-184. 5. Zuccato, E., Calamari, D., Natangelo, M. and Fanelli, R. (2000), Presence of therapeutic drugs in the environment, The Lancet, 355(9217), 1789-1790. 6. Mahnik, S., Rizovski, B, Fuerhacker, M. and Mader, R. (2004), Determination of 5-fluorouracil in hospital effluents, Anal Bioanal Chem., 380, 31-35. 7. Mahnik, S.N., Lenz, K., Weissenbacher, N., Mader, R.M. and Fuerhacker, M. (2007), Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system, Chemosphere, 66, 30-37. 8. Mullot, J.-U., Karolak, S., Fontova, A., Huart, B. and Levi, Y. (2009), Development and validation of a sensitive and selective method using GC/MS-MS for quantification of 5-fluorouracil in hospital wastewater, Anal Bioanal Chem., 394, 2203-2212. 9. Martin, J., Camacho-Munoz, D., Santos, J.L., Aparicio, I. and Alonso, E. (2011), Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography-triple-quadrupole mass spectrometry, Journal of Separation Science, 34, 3166-3177. 10. Kümmerer, K. (2004), Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, Springer London, Limited. 11. Ternes, T.A. (1998), Occurrence of drugs in German sewage treatment plants and rivers1dedicated to Professor Dr. Klaus Haberer on the occasion of his 70th birthday, Water Research, 32(11), 3245-3260. 12. Busetti, F., Linge, K.L. and Heitz, A. (2009), Analysis of pharmaceuticals in indirect potable reuse systems using solid-phase extraction and liquid chromatography tandem mass spectrometry, Journal of Chromatography, A 1216, 5807-5818. 13. Ghoshal, K. and Jacob, S. T. (1997), An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug Biochem, Pharmacol, 53 (11), 1569-1575. 14. Lo, Y., Shen, L.-J., Chen, W.-H., Dong, Y.-H. and Wu, F.-L.L. (2016), Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis, Journal of the Formosan Medical Association, 115, 744-751. 15. Jolivet, J., Cowan, K.H., Curt, G.A., Clendeninn, N.J. and Chabner, B.A. (1983), The Pharmacology and Clinical Use of Methotrexate, New England Journal of Medicine, 309, 1094-1104. 16. Kümmerer, K., Steger-Hartmann, T. and Meyer, M. (1997), Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage, Water Research, 31(11), 2705-2710. 17. Yu, J. T., Bouwer, E. J. and Coelhan, M. (2006), Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent, Agric. Water Manage, 86(1-2), 72-80. 18. Andreozzi, R., Raffaele, M. and Nicklas, P. (2003), Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment, Chemosphere, 50(10), 1319-1330. 19. Boreen, A. L., Arnold, W. A. and McNeill, K. (2004), Photochemical fate of sulfa drugs in the aquatic environment: Sulfa drugs containing five-membered heterocyclic groups, Environmental Science & Technology, 38(14), 3933-3940. 20. Lam, M.W. and Mabury, S.A. (2005), Photodegradation of the pharmaceuticals atorvastatin, carbamazepine, levofloxacin, and sulfamethoxazole in natural waters, Aquat Sci., 67, 177-188. 21. Lin, A.Y.C. and Reinhard, M. (2005), Photodegradation of common environmental pharmaceuticals and estrogens in river water, Environ Toxicol Chem 2005; 24:1303-1309Lovdahl, M.J., Priebe, S.R., 2000. Characterization of clinafloxacin photodegradation products by LC- MS/MS and NMR., J. Pharm. Biomed. Anal., 23, 521-534. 22. Packer, J. L., Werner, J. J., Latch, D. E., McNeill, K. and Arnold, W. A. (2003), Photochemical fate of pharmaceuticals in the environment: Naproxen, diclofenac, clofibric acid, and ibuprofen, Aquat. Sci., 65 (4), 342-351. 23. Piram, A., Salvador, A., Verne, C., Herbreteau, B. and Faure, R. (2008), Photolysis of β-blockers in environmental waters, Chemosphere, 73 (8), 1265-1271. 24. Tixier, C., Singer, H. P., Oellers, S. and Muller, S. R. (2003), Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters, Environ. Sci. Technol., 37(6), 1061-1068. 25. Lin A.Y.C., Lin YC, and Lee WN (2014), Prevalence and Sunlight Photolysis of Controlled and Chemotherapeutic Drugs in Aqueous Environments, Environmental Pollution, 187, 170-181. 26. Mack, J. and Bolton, J.R. (1999), Photochemistry of nitrite and nitrate in aqueous solution: A review, J Photoch Photobio., A 128, 1-13. 27. Mill, T. (1999), Predicting photoreaction rates in surface waters, Chemosphere 38, 1379-1390. 28. Zafiriou, O.C., Joussot-Dubien, J., Zepp, R.G. and Zika, R.G. (1984), Photochemistry of natural waters, Environ Sci Technol., 18:358A-371A. 29. Komori, K., Y. Suzuki, M. Minamiyama and A. Harada, (2013), Occurrence of selected pharmaceuticals in river water in Japan and assessment of their environmental risk, Environmental Monitoring and Assessment, 185(6), 4529-4536. 30. Lin A.Y.C., Wang XH, and Lee WN (2013), Phototransformation determines the fate of 5-fluorouracil and cyclophosphamide in Natural Surface Waters, Environmental Science & Technology, Apr., 47, 4104-4112. 42 Vol. 45, No. 4 August 2018